There were 2,001 press releases posted in the last 24 hours and 425,173 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
OSE Immunotherapeutics Presents its Novel Bispecific Checkpoint Inhibitor Platform, Targeting PD-1 and Innovative Targets at the 2019 World Immunotherapy Congress

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image